Gan & Lee Pharmaceuticals. (SHA:603087)
68.73
+0.83 (1.22%)
Jul 31, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 40.91 billion as of July 31, 2026. Its market cap has increased by 15.35% in one year.
Market Cap
40.91B
Enterprise Value
37.50B
Revenue
3.95B
Ranking
n/a
PE Ratio
39.68
Stock Price
68.73
ChartMarket Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 40.91B, an increase of 11.86%. That is a compound annual growth rate of 1.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 40.91B | 0.97% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 32.86B |
| Intco Medical Technology | 32.68B |
| Andon Health | 28.71B |
| iRay Group | 26.33B |
| Zhende Medical | 24.00B |
| Winner Medical | 17.86B |
| Shenyang Xingqi Pharmaceutical | 15.18B |
| Micro-Tech (Nanjing) Co.,Ltd | 13.60B |